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1. Introduction 
Our bodies are protected against a variety of external factors such as transient pathogens 
and can preserve homeostasis. This defense mechanism consists of many components, 
including antimicrobial lipids such as cis-6-hexadecenoic acid (C16:1Δ6) (Wille & 
Kydonieus, 2003) and sphingosine (Arikawa et al., 2002), as well as antimicrobial peptides 
such as ǃ-defensins and cathelicidin (Harder et al., 2010; Hsu et al., 2009; Tay et al., 2011). 
The levels of these antimicrobial components in the skin of atopic dermatitis (AD) patients 
are lower than those of healthy subjects (Arikawa et al., 2002; Harder et al., 2010; 
Takigawa et al., 2005). It has been reported that the uncommon lipid C16:1Δ6 is present as 
a major component of sebaceous lipids in human skin and hair but that it is not generally 
included in plant or animal oils. We have focused on this very unique unsaturated fatty 
acid, and have been investigating the relationship between this fatty acid and the resident 
flora of human skin as well as transient pathogens. In the course of that research, we 
found a correlation between C16:1Δ6 and AD, and have developed a method for the 
production of C16:1Δ6 on an industrial-scale (Araki et al., 2007; Koike et al., 2000a, 2000b; 
Takeuchi et al., 1990). In addition, we have made further progress in antimicrobial 
research involving C16:1Δ6 (Araki et al., 2005) and have selected fatty acid derivatives 
(oxa-fatty acids) with higher activity by means of analyses of structure-activity 
relationships (Sugai et al., in preparation). 
In this chapter, we introduce our research into fatty acids, and we also review approaches to 
normalizing AD from a microbiological point of view. 
2. Function of human sebaceous fatty acid “C16:1∆6” 
Human skin lipids, including sphingosine and C16:1Δ6, provide a defense against external 
factors and function to maintain homeostasis. It is well established that human skin lipids 
contribute to the defense mechanism termed “self-sterilization” (Wille & Kydonieus, 2003) 
and the antimicrobial activities of each lipid component have been evaluated (Arikawa et 
al., 2002; Harder et al., 2010). A significant difference was found in the fatty acid 
composition of sebum lipids between AD patients and healthy controls (Takigawa et al., 
2005). We describe the results of our investigation in the section below. 
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2.1 Cis-6-hexadecenoic acid (C16:1∆6) 
Cis-6-hexadecenoic acid, termed sapienic acid, is unique in the animal kingdom, being a 16-
carbon mono-unsaturated fatty acid with a cis-double bond located at the sixth carbon from 
the carboxyl terminal (Fig. 1). 
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Fig. 1. Structure of cis-6-hexadecenoic acid (C16:1Δ6) 
This fatty acid is an isomer of palmitoleic acid (cis-9-hexadecenoic acid (C16:1Δ9)), which is 
a common constituent of the glyceride of human adipose tissue. In addition, C16:1Δ6 is a 
major component of sebaceous wax esters, triacyl glycerols, and of free fatty acids found in 
skin and hair (Downing & Strauss, 1974; Morello & Downing 1976; Yamamoto et al., 1987). 
Sapienic acid represents 85% of the lipid in Thunbergia alata seed oil, and is obtained either 
by extraction of this plant or by chemical synthesis (Spencer et al., 1971). 
2.2 Relationship between human sebaceous fatty acid C16:1∆6 and AD 
The composition of free fatty acids in the sebum at the recovery level is shown in Figure 2 
(Takigawa et al., 2005). The level of C16:1Δ6 in healthy control skin ranged from 0.43 to 5.38 
μg/cm2 with a mean of 2.0 μg/cm2 (4.9 to 16.8% with a mean of 12.9% in percent of total) 
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Fig. 2. Amount of free fatty acid in sebum from AD patients (upper panel) and from healthy 
controls (lower panel). Sebum was analyzed at the recovery level. 
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and the total level of C16:0 ranged from 0.88 to 7.64 μg/cm2 with a mean of 3.43 μg/cm2 
(14.9 to 28.2% with a mean of 22.1% in percent of total). In contrast, the level of C16:1Δ6 (0.08 
to 0.53 μg/cm2 with a mean of 0.26 μg/cm2) and the percent of total (1.1 to 8.7% with a mean 
of 3.0% in percent of total) in the skin of AD patients were lower than in the healthy 
controls, although the amounts of C16:0 (0.53 to 2.84 μg/cm2 with a mean of 1.44 μg/cm2) 
and the percent of total (6.8 to 30.7% with a mean of 16.5% in percent of total) were similar 
to those of the healthy controls. A significant decrease in free C16:1Δ6 content in nonlesional 
skin from AD patients compared with healthy controls was found. 
2.3 Antibacterial activity of C16:1∆6: Selective antibacterial activity 
Colonization of S. aureus has been reported in AD patients and is regarded as an 
exacerbation factor (Akiyama et al., 1996). Antimicrobial agents, including C16:1Δ6, 
inhibited the growth of S. aureus at a final concentration of 100 mg/l in the following 
order; Benzalkonium chloride = Triclosan > C16:1Δ6 > Trichlorocarbanilide, while they 
inhibited the growth of S. epidermidis in the following order; Benzalkonium chloride = 
Triclosan> C16:1Δ6 = Trichlorocarbanilide (Fig. 3). Whereas C16:1Δ6 could inhibit the 
growth of S. aureus over a concentration range from 100 to 1000 ppm, it did not greatly 
inhibit S. epidermidis. 
In addition, the antibacterial mechanism of C16:1Δ6 against S. aureus and S. epidermidis was 
investigated using protoplasts treated with lysostaphin. The results of this experiment 
indicated that there was no difference in the effectiveness of C16:1Δ6 against S. aureus and S. 
epidermidis, and suggested that the antibacterial action of C16:1Δ6 against Staphylococcal 
bacteria was caused by disruption of the cell membrane, not disruption of the cell wall, and 
that this disruption resulted in leakage of bacterial components (Data not shown). 
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Fig. 3. Comparison of the antimicrobial effects of C16:1Δ6 against Staphylococcus aureus 
ATCC 12600T (left panel) and Staphylococcus epidermidis JCM 2414T (right panel). 
2.4 Topical application of C16:1∆6 to AD patients 
An inverse correlation between S. aureus colonization and the level of C16:1Δ6 in AD 
patients was found (Fig. 4). In addition, the colonization of S. aureus was reduced by 
topical application of C16:1Δ6 to the skin of six to eight AD patients in a small-scale 
clinical study. Based on these investigations, it was considered that the decreased level of 
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C16:1Δ6 in AD patients may be one of the factors that contribute to the colonization of S. 
aureus (Takigawa et al., 2005). 
We have confirmed that C16:1Δ6 functions as a natural antibacterial component and has 
very unique properties including “selective antibacterial activity”, in which it shows 
effective antibacterial activity against transient S. aureus but not against residential S. 
epidermidis. By topical application of this fatty acid to AD patients, the colonization of S. 
aureus, which is believed to be an exacerbation factor for this disease, was repressed, 
thereby indicating the effectiveness of this fatty acid. From the results of these 
investigations, a new approach for improvement of skin disorders, based on 
normalization of the microflora on human skin, was proposed using the selective 
antibacterial activity of C16:1Δ6. 
3. Proposed industrial production of C16:1∆6 using a bioreactor 
Microbial production of various materials has a number of advantages over chemical 
synthesis such as cost effectiveness, ease of production and regiospecific production. 
Considering the unique function of C16:1Δ6, and its potential therapeutic usefulness, we 
investigated the possibility of microbiologically producing C16:1Δ6. 
There are many reports regarding microbial production of polyunsaturated fatty acids 
under simple and mild conditions. The production of Ǆ-linoleic acid and arachidonic acid 
by species of the fungus Mortierella is a valuable product for many applications, and the 
triglyceride esters of poly unsaturated fatty acids that are produced in a fermentation 
process are used in skin care products (Certik & Shimizu, 1999a; Suzuki, 1987, 1988; 
Yamada et al., 1987) and baby formula (Certik & Shimizu, 1999b; Shinmen et al., 1989; 
Yamada, 1988). We isolated an alkane-assimilating Rhodococcus sp. strain from a soil 
sample and found that a mutant was capable of introducing a cis-double bond into 
various aliphatic substrates. We used this mutant for production of C16:1Δ6, investigated 
the production process, and further constructed a bioreactor system for its industrial 
production. 
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Fig. 4. Relationship between free C16:1Δ6 and S. aureus in the skin. A: in the skin of AD 
patients and Healthy Controls; B: in the skin of AD patients who exhibited more than 10 
counts/cm2 of S. aureus. AD patients; (●), Healthy Controls; (∆) 
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3.1 Desaturation reaction of aliphatic substrates by a mutant strain of alkane-
assimilating Rhodococcus sp. 
We found that the double mutant designated Rhodococcus sp. KSM-MT66 had the ability to 
desaturate various aliphatic compounds such as alkanes, chloro alkanes and fatty acid 
esters, and that this mutant strain produced unsaturated compounds extracellularly. When 
hexadecanoic acid esters such as methyl, propyl, isopropyl, and isobutylester were supplied 
as substrates to the resting cells, their corresponding cis-desaturated compounds were 
produced at a concentration of 0.5, 20, 53 and 7 g/l in 3 days. The enzyme(s) responsible for 
the desaturation reaction appears to recognize mainly the sixth carbon from the carbonyl 
carbons (Fig. 5). The bioproduction of C16:1Δ6 esters has not been previously reported 
(Koike et al., 1999). When alkanes were supplied to this mutant strain, the main products 
had a double bond at the ninth carbon from the terminal methyl group. These experiments 
indicated that the unsaturated position differed according to differences in the supplied 
substrates (Koike et al., 2000a). 
 
 
 
Fig. 5. The patterns of regiospecific desaturation of aliphatic substrates by Rhodococcus sp. 
strain KSM-MT66 cells. 
3.2 Production of a C16:1∆6 ester by resting cells of Rhodococcus sp. KSM-MT66 
We determined the condition with resting cells of the Rhodococcus sp. KSM-MT66 strain to 
produce C16:1Δ6. The reaction mixture contained 20% (w/v) hexadecanoic acid isopropyl 
ester (IP-C16:0), 0.25 M phosphate buffer (pH 7.0), 1.0% (w/v) monosodium glutamate, 2 
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mM thiamine, 2 mM MgSO4, and 5% (wet w/v) resting cells. Bioconversion was performed 
using a 1.0 l working volume in a 2.6 l bioreactor at 26 ºC with aeration and agitation. 
Glutamate, thiamine, and MgSO4 prevented cell damage of this strain during repeat-batch 
bioconversion, and optimum concentrations of these factors were maintained in the reaction 
mixture. Under optimum conditions, about 50 g/l of C16:1Δ6 isopropyl ester (IP-C16:1Δ6) 
was produced extracellularly in 3 days. 
Since this reaction mixture consisted of water, oil and cells, we considered that this may 
make it difficult to separate the products. We therefore designed a new process to recover 
the products. Thus, the oil in water (O/W-type) emulsified reaction mixture was kept 
without agitation for 20 hours, the water layer was drained out, an appropriate volume of 
substrate, IP-C16:0, was added to the reaction mixture to invert the emulsion phase to a 
W/O-type, and the product, IP-C16:1Δ6, in the continuous oil phase was recovered through 
a hydrophobic hollow-fiber module (Fig. 6). The hydrophobic cells were concentrated in the 
oil phase. It was then possible to start the next batch by adding fresh medium to these cells 
(Koike et al., 2000b; Takeuchi et al., 1990). This system allows repeat-batch reactions without 
having to use an organic solvent to recover the products. 
 
 
 
Fig. 6. Schematic diagram of the membrane bioreactor system for Rhodococcal 
bioconversion. (A) Reactor vessel; (B) Hydrophobic hollow-fiber module; (C) Circulation 
pump. 
3.3 Repeat-batch production of the C16:1∆6 ester 
The reason for the decline in late production during repeat batch production may be due to 
various factors such as accumulation of some inhibitory products, cell damage and/or 
exhaustion of some nutrients. Since monosodium glutamate was found to reduce cell 
damage, we investigated the effect of monitoring and adjusting the concentration of 
monosodium glutamate on productivity during repeat batch production (see sec. 3-2). The 
results of this experiment showed that a productivity of 0.8 g/l was attained over the course 
of 13 cycles (300 hours) by maintaining the concentration of monosodium glutamate 
between 0.5 and 1.5% (Fig. 7). It was possible to recover the produced IP-C16:1Δ6 using the 
hollow-fiber system, and IP-C16:1Δ6 was then purified by urea adduct treatment, 
evaporated and applied to a silica gel column. The total yield of IP-C16:1Δ6 using this 
procedure was 79% and the purity was over 97%. Long term operation of C16:1Δ6 ester 
production was achieved using a 2.6 l fermentor (Koike et al., 2000b).  
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Fig. 7. Repeat-batch reaction using a membrane bioreactor system with a phase inversion for 
the production of IP-C16:1Δ6 by the resting cells of Rhodococcus sp. KSM-MT66. 
3.4 Fermentative production of IP-C16:1∆6 using growing cells of the mutant 
Rhodococcus sp. KSM-MT66 
The resting cell production of IP-C16:1Δ6 described above includes four complicated steps; 
(i) cell growth, (ii) cell harvesting, (iii) incubation of cells with substrate and (iv) phase-
inversed separation of the product using a hydrophobic fiber membrane system.  
In order to develop a more convenient production process we therefore investigated 
production of IP-C16:1Δ6 using a fermentation process. We first established a basal medium 
for Rhodococcus sp. KSM-MT66. When production was performed under resting cell 
conditions, 18 g/l of IP-C16:1Δ6 was produced over 3 days of cultivation. Optimization of 
the concentrations of metal ions greatly improved production of IP-C16:1Δ6, resulting in 
production of 52 g/l over 4 days of cultivation (see sec. 3.5). 
3.5 Fermentative production of IP-C16:1∆6 using the mutant Rhodococcus sp. KSM-
T64 
Since there was a possibility that the IP-C16:1Δ6 product might be degraded by esterases 
present in the Rhodococcus sp. KSM-MT66, we attempted to create Rhodococcus mutants with 
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reduced esterase activity by UV irradiation. Of the colonies which showed lower growth 
than KSM-MT66 on the minimum agar containing IP-C16:0, one mutant, designated KSM-
T64, displayed 40% of the esterase activity of KSM-MT66. 
Using this mutant strain T64, and optimizing culture conditions, more than 60 g/l of IP-
C16:1Δ6 could be produced in a flask (Table 1). Optimization of culture conditions in a 30 l 
jar fermentor, resulted in production of 50 g/l over 4 days of cultivation (Fig. 8). 
Furthermore, C16:1Δ6 can be easily obtained by simple hydrolysis of IP-C16:1Δ6 (Araki et 
al., 2007). 
 
Reaction condition KSM- MT66 KSM-T64 
Reaction process Resting Growing 
Reaction 
ingredient 
Monosodium glutamate 1.0% 2.0% 
Metal 
MgSO4·7H2O 2 mM 2 mM 
MnSO4·6H2O -a 2 µM 
FeSO4·7H2O - 60 µM 
CuSO4·5H2O - 5 µM 
ZnSO4·7H2O - - 
Thiamine 2 mM - 
Yeast extract (P-21) - 0.8% 
Phosphate buffer 
250 mM 350 mM 
pH 7 pH 7.3 
IP-C16:0 20% 22% 
IP-C16:1 productivity 50 g l-1 61 g l-1 
a Not added. 
Table 1. Production of IP-C16:1Δ6 by Rhodococcus sp. KSM-MT66 and KSM-T64.  
4. The production of C16:1∆6 by genetically modified bacteria: Cloning and 
expression of two novel desaturases from Rhodococcus sp. 
4.1 Review of desaturase studies 
An enzyme that removes hydrogen atoms from a fatty acid derivative, thereby creating a 
double bond, is called a desaturase, and desaturases are key enzymes for the maintenance of 
cell life cycles. Desaturases are divided into three types based on substrate specificity; acyl-
CoA, acyl-ACP, and acyl-lipid types (Fox et al., 2004). Desaturases are further sub-divided 
into membrane-bound and soluble types. Membrane-bound enzymes are very unstable and 
are known to be very difficult to purify. However, recently a very interesting report has 
been published regarding the purification of human stearoyl-CoA desaturase (Gorden & 
Fox, 2008). In contrast, there have been some reports regarding the purification and 
clarification of the crystal structure of the soluble types of enzymes (Lindqvist et al., 1996). 
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Delta 6-desaturases have been reported to be obtained from animals, plants, fungi and 
cyanobacteria (Aki et al., 1999; Cahoon et al., 1994; Inagaki et al., 2003; Okayasu et al., 
1981; Reddy & Thomas, 1996; Zhan et al., 2004). Human and rat fatty acid desaturase 2 
(FADS2) -encoding delta 6-desaturases recognize a saturated fatty acid as a substrate 
under some conditions (Ge et al., 2003; Guillou et al., 2003), and a human delta 6-
desaturase gene has been reported to be expressed only in the sebaceous gland. Regarding 
microbial delta 6-desaturases, industrial producers of unsaturated fatty acids have 
focused mainly on fungi of the Mortierella spp., especially Mortierella alpina and Mortierella 
cincinelloides. Two types of delta 6-desaturases have been reported to be expressed by 
Mortierella alpina. The corresponding genes were isolated and the sequences and functions 
of these genes have been analyzed (Huang et al., 1999; Sakuradani et al., 1999; Sakuradani 
& Shimizu, 2003). However, even though many delta 6-desaturase genes have been 
obtained, no delta 6-desaturase genes have been purified from Rhodococcus sp. 
We aimed to obtain delta 6-desaturase genes from the Rhodococcus sp. KSM-T64 strain, 
which shows 40% of the esterase activity of the parent strain, KSM-MT66. 
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Fig. 8. Production of IP-C16:1Δ6 in a 30 l-jar fermentor under optimized conditions. 
IP-C16:1Δ6 (●), monosodium glutamate (MSG) (○). Cultivation was performed at 26 ºC, with 
agitation at 350 rpm, aeration at 0.3 vvm and pressure at 0.2 kg/cm2. The Rhodococcus sp. 
KSM-T64 was used. 
4.2 Cloning of delta 6-desaturase genes from the Rhodococcus sp. KSM-T64 strain 
The production of IP-C16:1Δ6 by Rhodococcus sp. was improved by the addition of metal 
ions as mentioned above. We therefore targeted the membrane-bound delta 6-desaturase 
and attempted to clone a gene whose encoded protein could introduce a cis-double bond. 
We cloned the delta 6-desaturase gene on the basis of previously reported conserved 
sequences. Histidine motifs (Shanklin & Fox, 1994; Shanklin, 2009) that bind to ferric ions 
and whose sequences are known to be conserved in membrane-bound desaturases in a 
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number of species including worms, borages, Mucor sp. and Mortierella sp., were targeted 
for primer design for PCR amplification (Fig. 9). These primers were used for degenerated 
PCR and nested PCR. In addition, inverse PCR was performed using the obtained PCR 
products. Approximately 5.5 kbp of sequence was obtained using these methods. Within 
this sequence, there were sequences that corresponded to two tandem desaturase-like 
proteins; the first ORF (Rdes1) was comprised of 420 amino acids and the second ORF 
(Rdes2) was comprised of 413 amino acids from inffered start codons individually. The 
estimated molecular mass of the Rdes1 protein was 47985 Da and that of Rdes2 was 46951 
Da. Three histidine motifs that are established consensus sequences in desaturase proteins 
were found in these ORF sequences (Fig. 10). 
 
 
WWXXXHXXHH XXQIEHHLFPWXXHXXXH
Mortierella alpina 1S-4
Borago officinalis
Caenorhabditis elegans
Rattu norvegicus
Homo sapiens
WLAHDFLH
WIGHDAGH
WLTHEFCH
WLQHDYGH
WLQHDYGH
WWKDKHNTHH
WWKWNHNAHH
WWKDKHNTHH
WWNHRHFQHH
WWNHRHFQHH
NYQIEHHLFP
QFQIEHHLFP
NVQIEHHLFP
NFQIEHHLFP
NFQIEHHLFP
His box1 His box2 His box3
1 2
3 4
 
Fig. 9. Construction of PCR primers based on the histidine motifs that are conserved among 
delta 6-desaturases obtained from various organisms. 
The sequence of primers 1, 2, 3, and 4 was; 5’-YTGGTGGAAGGRYAABCAYAA-3’, 5’-
RGGGAAVARRTGGTG-3’, 5’-CAYAAYNMDCAYCA-3’, and 5’-RGGGAAVARRTGGTG-3’ 
respectively. Y, R, B, N, M, D, V, and W were mixed primers of C/T, AA/G, C/T/G, 
A/C/G/T, A/C, A/G, A/C/G and A/T respectively. 
Among the membrane-bound delta 6-desaturases which were clarified the function except 
for putative and probable delta 6-desaturases, Rdes1 and Rdes2 had about 30% to Homo 
sapiens as an amino acid sequence. An unknown ORF whose function has not yet been 
clarified is present upstream of these two delta 6-desaturase genes. A domain search 
revealed that this ORF had an oxidoreductase NAD-binding domain, an oxidoreductase 
FAD-binding domain, a 2Fe-2S iron·sulfur cluster domain and a ferric reductase domain 
(data not shown). 
4.3 Expression of delta 6-desaturase genes in Escherichia coli 
Plasmids incorporating the delta 6-desaturase genes Rdes1 and Rdes2 were individually 
introduced into competent E. coli BL21 (DE3) cells, and the corresponding proteins were 
produced by IPTG induction. Production of very high amounts of these proteins was 
confirmed using SDS-PAGE. The molecular mass of each of these expressed proteins was 45 
kDa. These proteins were identified by comparison with a control cell lysate which was 
prepared from cells transformed with vector alone. 
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Fatty acids extracted from E.coli transformants that expressed Rdes1 and Rdes2 were 
analyzed using GC and GC/MS. The level of C16:1Δ6 was increased 2.5-fold in the Rdes1-
expressing transformant and 4.8-fold in the Rdes2-expressing transformant, over that of 
control.  
Although the level of C16:1Δ6 fatty acids in the transformants was higher than that of 
control, it was unclear if these delta 6-desaturase genes of the Rhodococcus sp. produced 
extracellular IP-C16:1Δ6 or not (Araki et al., 2005). 
 
 
ORF1(mature) 1:VAITDIKEFSHLTEADVEALGRELDQIRLDIEDSRGIRDARYIRRVIRVQRALELGGRIA 60
ORF2(mature) 1:MAIADVKEYAHLTDADIEALGRELDAIRRDIEESRGEKDARYVRNVIRLQRSLEIGGRAV 60
** * **  *** ** ******** ** *** ***  **** * *** ** ** ***
61:LFGSRYRPAWLVGTTLLSLSKIIENMELGHNVMHGQWDWMNDPEIHSVSWEWDQTGPSEH 120
61:LFASRRRPAWLAGVGLLTLSKIIENMELGHNVMHGQWDWMNDPEIHSTSWEWDVTGPSAH 120
** ** ***** *  ** ***************************** ***** **** *
121:WKRAHNYQHHTYTNVVGMDEDLGFGILRMTRDEPWKPINLFQPIANVILAATFEWGIALH 180
121:WKQTHNYLHHKYTNVLGMDDDVGYGLLRVTRDQRWKPFNAGNLVYNTLLALFFEYGIAAQ 180
**  *** ** **** *** * * * ** ***  *** *   *  **  ** ***
181:DLTAAAELEGAE-KGQLNSQANKDFARKIFRQVGKDFILFPALTGPAWKSTMSANATANL 239
181:HLELGKVAKGRADKEETQRKLRE-VGEKIGKQVLRDYVIYPAITGPAWKSTLSANFTANT 239
*       *   *             **  **  *    ** ******** *** ***
240:VRNLWAYVVIFCGHFPDGAEKFTVAEFEQETRHEWYLRQMLGSANFNSGKLMGLMSGNLS 299
240:LRNVWTNAVIFCGHFPDGAEKFTKEDIDKETQAQWYLRQMLGSANIEGSALMDFMTGNLS 299
** *   ***************      **   ***********     **  * ****
300:YQIEHHVFPDLPSNRYPEIAVKMRALCEKFDLPYTTGSLFKQYLLALRTIHKLALPDKWL 359
300:YQIEHHLFPDLPSNRYKDIAVTVRQLADKYDLPYTTGPLAVQYAKSWRTIAKLSLPNKYL 359
****** *********  ***  * *  * ******* *  **    *** ** ** * *
360:TATSDNAPETSSELRFRDSGFRDAAMAMVEDLRTDPITGKRLGLLTALKSQARS---R-- 414
360:KDTVDNAPETASERMFD------GELTS--TV--DPVTGRRSGLKSAIARKRKSGKLRSL 409
* ****** **  *                  ** ** * **  *      *   *
415:MPKRRK                                                      420
410:LGLR-- 413
*
His box1
His box2
His box3
ORF1(mature)
ORF2(mature)
ORF1(mature)
ORF2(mature)
ORF1(mature)
ORF2(mature)
ORF1(mature)
ORF2(mature)
ORF1(mature)
ORF2(mature)
ORF1(mature)
ORF2(mature)
ORF1(mature)
ORF2(mature)
 
 
Fig. 10. Sequence homology of the proteins encoded by Rdes1 (ORF1) and Rdes2 (ORF2). 
The homology search was performed using Genetyx Win ver.6.1. The gap penalty score was 
set at –10 as an insert and –3 as an extend. The three histidine rich regions (Histidine motifs) 
that are conserved in membrane binding desaturases are boxed. 
5. Further investigation of human sebaceous fatty acids combined with 
chemical synthesis: Structure-activity relationship of oxa-fatty acids 
C16:1Δ6 has a double bond and, consequently, its stability is a concern, which raises doubts 
regarding adequate stability of C16:1Δ6 in products. The stability of C16:1Δ6 can be 
improved by replacing the unsaturated fatty acids with the corresponding oxa-fatty acids 
(Alkoxy fatty acids). Such a change would also be expected to lead to an improvement in 
antimicrobial properties of the fatty acid. We describe the results of our investigations 
regarding such a replacement in the section below. 
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5.1 Review of the antimicrobial activities of oxa-fatty acids 
Although oxa-fatty acids are widely used as intermediate chemicals in fine chemical fields 
such as medicine, agriculture and fragrance, there have only been a few reports of the 
antimicrobial activity of oxa-fatty acids. N-alkoxyacetic acid and its methyl ester showed 
good antifungal activity against Aspergillus niger, Myrothecium verrucaria, and Trichoderma 
viride (Gershon et al., 1979). In addition, 4-oxatetradecanoic acid, which is an inducer of 
myristic acid ǃ-oxidation, displayed antifungal activity against Cryptococcus neoformans and 
also antiviral activity against human immunodeficiency virus I (Langner et al., 1992). These 
studies indicate that oxa-fatty acids of C16:1Δ6, in which the double bond has been replaced 
with an ether bond (7-oxaheptadecanoic acid or 6-decyloxy hexanoic acid), will maintain 
their antibacterial activity and will also have a novel function, that is antifungal activity.  
5.2 Synthesis and evaluation of a C16 oxa-fatty acid 
An oxygen-containing analog of C16:1Δ6 (oxa-fatty acid:7-oxaheptadecanoic acid) was 
synthesized by condensation of n-decanol with 6-bromo-hexanoic acid under alkaline 
conditions. The antimicrobial activities of purified 7-oxaheptadecanoic acid were then 
compared with those of C16:1Δ6. The oxa-fatty acid analog of C16:1Δ6, 7-
oxaheptadecanoic acid, retained the selective antimicrobial activity of C16:1Δ6, being 
effective against S. aureus but not against S. epidermidis (Fig. 11), and, displayed similar 
activity to C16:1Δ6 against Propinibacterium acnes, which is associated with AD (Ishibashi 
et al., 2009). In addition, 7-oxaheptadecanoic acid had gained an additional anti-yeast 
activity against Malassezia, which is associated with skin disorders such as seborrhea 
dermatitis and AD (Tajima et al., 2008). Moreover, the best molecule for treatment of skin 
disorders such as seborrhea dermatitis and AD could be selected by means of structure-
activity relationships (Sugai et al., in preparation).  
 
 
 
 
 
 
Fig. 11. Antibacterial activity of 7-oxaheptadecanoic acid. A: S. aureus; B: S. epidermidis 
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6. Conclusion 
We found that cis-6-hexadecenoic acid (C16:1Δ6) displayed a selective antimicrobial activity 
that was unique among human sebaceous lipids. It was suggested that topical application of 
C16:1Δ6 to the skin of AD patients, who have lower levels of C16:1Δ6 in skin lipids than 
healthy controls, was effective for treatment of this skin condition. We proposed an 
industrial process for the production of C16:1Δ6 using Rhodococcus sp. An oxygen-
containing analog of C16:1Δ6 (7-oxaheptadecanoic acid) was found to be more effective 
against microorganisms such as S.aureus and Malassezia sp. that are associated with skin 
disorders. It was proposed that the best oxa-fatty acid derivative of C16:1Δ6 could be 
selected by analysis of structure-activity relationships. 
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